#1 out of 1
health1d ago
Investing in HIV and Cancer Treatments Fuels the Economy With Trillions of Dollars
- A U.S. Chamber of Commerce study finds medical innovation yielded $167.5 trillion in value over 30 years, with a 27-to-1 ROI.
- HIV innovations, including testing and antiretroviral therapy, produced $22 trillion in health gains over 30 years.
- Breast cancer treatments yielded substantial health gains, with estimates approaching the size of the U.S. economy’s annual output.
- Obesity therapies, including GLP-1 drugs, are projected to add major health value and longer lifespans.
- Overall health improvements translated into higher productivity and tax revenue over decades.
- Heart disease and obesity innovations also contributed to substantial economic and health benefits.
- The report indicates a positive return even after analyzing higher healthcare spending.
- Treating these conditions benefits the public by building larger, more productive workforces.
- The analysis uses life expectancy gains and the Value of a Statistical Life Year to quantify benefits.
- The study highlights HIV as a treatable chronic condition with U=U benefits.
Vote 0
